Akèy › Skleroz Miltip › Illinois
Etid klinik pou Skleroz Miltip nan Illinois
19 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Illinois.
Vil nan Illinois
Tèks ofisyèl etid la (Anglè)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Chicago
- TG Therapeutics Investigational Trial Site, Chicago
- TG Therapeutics Investigational Trial Site, Evanston
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Consultants in Neurology- Site Number : 8400020, Northbrook
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of Chicago Medical Center, Chicago
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 10, 2026 · NCT06408259Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain
- Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT07132775A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Northwestern Memorial Hospital, Chicago
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Ocrevus Zunovo for MS: Mixed Methods
- Northwestern Memorial Hospital, Chicago
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT07710105Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device
- University of Illinois at Chicago, Chicago
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT06410261Functional Balance Intervention in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Jul 6, 2026 · NCT06341023Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Jun 4, 2026 · NCT05051618Nomad P-KAFO Study
- Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 89 · Tout sèks · Mizajou May 11, 2026 · NCT05644522Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters
- Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT07167680Intermittent Hypoxia in Persons With Multiple Sclerosis
- Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Mar 20, 2026 · NCT06276634Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis
- Northwestern Memorial Hospital, Chicago
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Mar 17, 2026 · NCT07225361People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists
- Northwestern Memorial Hospital, Chicago
Ap rekriteEtid obsèvasyon
Laj 18 a 70 · Tout sèks · Mizajou Mar 17, 2026 · NCT07207148Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
- Shirley Ryan AbilityLab, Chicago
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Feb 23, 2026 · NCT06390930Home Based Functional Balance Intervention for Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Ap rekrite
Laj 40 a 90 · Tout sèks · Mizajou Jan 21, 2026 · NCT07355387An Individualized-health eLibrary App for People With Multiple Sclerosis
- University of Illinois Urbana-Champaign, Champaign
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT05124600Remote Evaluation of MIND Diet
- University of Illinois Urbana-Champaign, Urbana
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Jun 27, 2024 · NCT06450977Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.